Abstract
Shagari</div>, < (2024). High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya. Afribary. Retrieved from https://afribary.com/works/high-seroprevalence-of-immunoglobulin-g-igg-and-igm-antibodies-to-sars-cov-2-in-asymptomatic-and-symptomatic-individuals-amidst-vaccination-roll-out-in-western-kenya
Shagari</div>, <div>Awandu "High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya" Afribary. Afribary, 04 Jun. 2024, https://afribary.com/works/high-seroprevalence-of-immunoglobulin-g-igg-and-igm-antibodies-to-sars-cov-2-in-asymptomatic-and-symptomatic-individuals-amidst-vaccination-roll-out-in-western-kenya. Accessed 16 Sep. 2024.
Shagari</div>, <div>Awandu . "High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya". Afribary, Afribary, 04 Jun. 2024. Web. 16 Sep. 2024. < https://afribary.com/works/high-seroprevalence-of-immunoglobulin-g-igg-and-igm-antibodies-to-sars-cov-2-in-asymptomatic-and-symptomatic-individuals-amidst-vaccination-roll-out-in-western-kenya >.
Shagari</div>, <div>Awandu . "High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya" Afribary (2024). Accessed September 16, 2024. https://afribary.com/works/high-seroprevalence-of-immunoglobulin-g-igg-and-igm-antibodies-to-sars-cov-2-in-asymptomatic-and-symptomatic-individuals-amidst-vaccination-roll-out-in-western-kenya